U.S. AI Diabetic Retinopathy Screening Market Forecast: Rising Adoption of AI-Based Eye Screening Systems
The U.S. AI diabetic retinopathy screening market is experiencing significant growth as healthcare providers increasingly adopt artificial intelligence (AI)-powered diagnostic technologies to improve early detection and management of diabetic eye diseases. Diabetic retinopathy is one of the leading causes of vision impairment among working-age adults and occurs when prolonged high blood sugar levels damage the blood vessels in the retina. Early screening and timely intervention are essential to prevent severe vision loss. The U.S. AI-driven diabetic retinopathy screening market was valued at USD 184.15 million in 2025 and is projected to reach USD 1,081.73 million by 2034, registering a CAGR of 21.74% during the forecast period. Market Scope Increasing Adoption of AI-Based Diagnostic Technologies The growing acceptance of artificial intelligence in healthcare is a major factor supporting the expansion of the U.S. AI diabetic retinopathy screening market. AI algorithms can ...